Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Yuning Liu,Qingzhe Wu,Bin Jiang,Tingting Hou,Chuanqiang Wu,Ming Wu,Hai Song

DOI: https://doi.org/10.1158/1541-7786.26144994

2024-01-01

Abstract:Supplementary Table S1. Sequences for sgRNA, shRNA or siRNA.

What problem does this paper attempt to address?

Supplementary Table 4 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John S. Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen K. Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528419.v1

2023-01-01

Abstract:PDF file, 53K, mRNA transcripts significantly different between SCLC and NSCLC cell lines.
Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528425

2023-01-01

Abstract:PDF file, 64K, Non-small cell lung cancer cell lines.
Distinct regulation of ASCL1 by the cell cycle and chemotherapy in small cell lung cancer

Yuning Liu,Qingzhe Wu,Bin Jiang,Tingting Hou,Chuanqiang Wu,Ming Wu,Hai Song

DOI: https://doi.org/10.1158/1541-7786.mcr-23-0405

2024-03-23

Molecular Cancer Research

Abstract:Small cell lung cancer (SCLC) is an aggressive and lethal malignancy. Achaete-scute homolog 1 (ASCL1) is essential for the initiation of SCLC in mice and the development of pulmonary neuroendocrine cells (PNECs) which are the major cells of origin for SCLC. However, the regulatory mechanism of ASCL1 in SCLC remains elusive. Here, we found that ASCL1 expression gradually increases as the tumors grow in a mouse SCLC model and is regulated by the cell cycle. Mechanistically CDK2-CyclinA2 complex phosphorylates ASCL1, which results in increased proteasome-mediated ASCL1 protein degradation by E3 ubiquitin ligase HUWE1 during mitosis. TCF3 promotes the multi-site phosphorylation of ASCL1 through the CDK2-CyclinA2 complex and the interaction between ASCL1 and TCF3 protects ASCL1 from degradation. The dissociation of TCF3 from ASCL1 during mitosis accelerates the degradation of ASCL1. In addition, chemotherapy drugs greatly reduce the transcription of ASCL1 in SCLC cells. Depletion of ASCL1 sensitizes SCLC cells to chemotherapy drugs. Together, our study demonstrates that ASCL1 is a cell-cycle regulated protein and provides a theoretical basis for applying cell-cycle related antitumor drugs in SCLC treatment. Implications: Our study revealed a novel regulatory mechanism of ASCL1 by cell cycle and chemotherapy drugs in SCLC. Treating SCLC patients with a combination of ASCL1-targeting therapy and chemotherapy drugs could potentially be beneficial.

oncology,cell biology
Table S1 from Spi-B–Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors

Wei Du,Xing Xu,Qing Niu,Xuexi Zhang,Yiliang Wei,Ziqiao Wang,Wei Zhang,Jun Yan,Yongxin Ru,Zheng Fu,Xiaobo Li,Yuan Jiang,Zhenyi Ma,Zhenfa Zhang,Zhi Yao,Zhe Liu

DOI: https://doi.org/10.1158/0008-5472.22415547.v1

2023-01-01

Abstract:Table S1. Oligonucleotide sequences used for RT-PCR, ChIP, 3C assays and luciferase reporters
Supplementary Tables from A Novel Micropeptide Encoded by Y-Linked LINC00278 Links Cigarette Smoking and AR Signaling in Male Esophageal Squamous Cell Carcinoma

Siqi Wu,Liyuan Zhang,Jieqiong Deng,Binbin Guo,Fang Li,Yirong Wang,Rui Wu,Shenghua Zhang,Jiachun Lu,Yifeng Zhou

DOI: https://doi.org/10.1158/0008-5472.22425229.v1

2023-01-01

Abstract:Supplementary Tables. Table S1. Distributions of characteristics among male ESCC patients in Chinese populations used for study. Table S2. Used Primers and shRNAs/siRNAs in this study. Table S3. Characteristics of cell lines used in this study.
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
Supplementary Table 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

Xiangchun Li,William K.K. Wu,Rui Xing,Sunny H. Wong,Yuexin Liu,Xiaodong Fang,Yanlin Zhang,Mengyao Wang,Jiaqian Wang,Lin Li,Yong Zhou,Senwei Tang,Shaoliang Peng,Kunlong Qiu,Longyun Chen,Kexin Chen,Huanming Yang,Wei Zhang,Matthew T.V. Chan,Youyong Lu,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22410795.v1

2023-01-01

Abstract:Supplementary Table 1: Published publications and cohorts
Supplementary Table 1 from Hypoxic Glioma Stem Cell–Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis

Junjun Li,Tingting Liao,Hongya Liu,Hongliang Yuan,Taohui Ouyang,Jiajing Wang,Songshan Chai,Jinsong Li,Jingchao Chen,Xiang Li,Hongyang Zhao,Nanxiang Xiong

DOI: https://doi.org/10.1158/0008-5472.22427395.v1

2023-01-01

Abstract:Table S1: the sequences of relative siRNAs and shRNAs.
Supplemental Table 1 from Genetic Variation in an Mirna-1827 Binding Site in MYCL1 Alters Susceptibility to Small-Cell Lung Cancer

Fang Xiong,Chen Wu,Jiang Chang,Dianke Yu,Binghe Xu,Peng Yuan,Kan Zhai,Jian Xu,Wen Tan,Dongxin Lin

DOI: https://doi.org/10.1158/0008-5472.22388229

2023-01-01

Abstract:Supplemental Table 1 from Genetic Variation in an miRNA-1827 Binding Site in MYCL1 Alters Susceptibility to Small-Cell Lung Cancer
Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Yong Guo,Zhaoli Chen,Liang Zhang,Fang Zhou,Susheng Shi,Xiaoli Feng,Baozhong Li,Xin Meng,Xi Ma,Mingyong Luo,Kang Shao,Ning Li,Bin Qiu,Keith Mitchelson,Jing Cheng,Jie He

DOI: https://doi.org/10.1158/0008-5472.22371494

2023-01-01

Abstract:Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma
Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities

Yibin Dai,Ziyu Wang,Yi Xia,Li Jin,Yaping Wu,Yanling Wang,Hongbing Jiang,Jie Cheng

DOI: https://doi.org/10.1158/1078-0432.23814224

2023-01-01

Abstract:Detailed proportions of cells in 5 scRNA-seq datasets
Supplementary Tables 1-4 from Targeting FBW7 As a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Mingxiang Ye,Yong Zhang,Xinxin Zhang,Jianbin Zhang,Pengyu Jing,Liang Cao,Nan Li,Xia Li,Libo Yao,Jian Zhang

DOI: https://doi.org/10.1158/0008-5472.22413117

2023-01-01

Abstract:This supplementary tables contain shRNAs, siRNAs, primers sequences and antibody resources.
Supplementary Tables from The Open Chromatin Landscape of Non–Small Cell Lung Carcinoma

Zhoufeng Wang,Kailing Tu,Lin Xia,Kai Luo,Wenxin Luo,Jie Tang,Keying Lu,Xinlei Hu,Yijing He,Wenliang Qiao,Yongzhao Zhou,Jun Zhang,Feng Cao,Shuiping Dai,Panwen Tian,Ye Wang,Lunxu Liu,Guowei Che,Qinghua Zhou,Dan Xie,Weimin Li

DOI: https://doi.org/10.1158/0008-5472.22422308.v1

2023-01-01

Abstract:<p>SF1:Table S1. The Clinical information and pathologic characteristics of 47 NSCLC patients and 4 non-malignant nodules patients; SF2:Table S2. Information of DNA-seq, RNA-seq, ATAC-seq and single-cell ATAC-seq; SF3:Table S3. Significant amplication and deletion regions of LUAD and LUSC samples (Genes marked in red were known cancer genes); SF4:Table S4. GREAT enrichment of common open regions; SF5:Table S5. Expression change of cluster II specific open peak related genes. SF6:Table S6. Sample Information and classification; SF7:Table S7. Sub cluster 2 specific region GREAT enrichment; SF8:Table S8. broad open chromatin region related genes; SF9:Table S9. sCOP and their accosiated DEGs; SF10:Table S10. Known important NSCLC related genes were affected by sCOP; SF11:Table S11. Joint-QTLs and Genes; SF12:Table S12. Haplotype blocks harboring both joint-QTL and GWAS lead SNP of lung cancer;</p>
Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Yan Wang,Jian Gu,Jack A. Roth,Michelle A.T. Hildebrandt,Scott M. Lippman,Yuanqing Ye,John D. Minna,Xifeng Wu

DOI: https://doi.org/10.1158/0008-5472.22396955

2023-01-01

Abstract:PDF file - 97K, Supplementary Table S1 summarized numbers of miRNA binding sites in TGF-beta pathway-related genes; Supplementary Table S2 showed raw Ct values and normalized expression levels of 35 miRNAs for qRT-PCR assays in 383 serum samples from the NSCLC study population recruited at the University of Texas MD Anderson Cancer Center between 2002 and 2009; Supplementary Table S3 showed differentially expressed serum miRNAs between Stage III and Stage IV groups for NSCLC study population recruited at the University of Texas MD Anderson Cancer Center between 2002 and 2009.
Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Xia Pu,Jack A. Roth,Michelle A.T. Hildebrandt,Yuanqing Ye,Hua Wei,John D. Minna,Scott M. Lippman,Xifeng Wu

DOI: https://doi.org/10.1158/0008-5472.22399995.v1

2023-01-01

Abstract:Supplementary Table 1-3 PDF file - 162K, Supplementary tables 1 and 2 include effect of selected SNPs on overall survival or recurrence in early stage NSCLC patients; Supplementary table 3 includes all the SNPs selected in the analysis
Supplementary Table S6 from YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer

Hongtao Song,Tong Lu,Donghui Han,Jiayu Zhang,Lunbiao Gan,Chao Xu,Shaojie Liu,Peng Li,Keying Zhang,Zhihao Hu,Hongji Li,Yu Li,Xiaolong Zhao,Jingliang Zhang,Nianzeng Xing,Changhong Shi,Weihong Wen,Fa Yang,Weijun Qin

DOI: https://doi.org/10.1158/0008-5472.27837565

2024-01-01

Abstract:Supplementary Table 6: The clinical information of scRNA-seq data and the numbers of cells in each sample
Supplementary Table S2 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence

Xin Zhang,Limei Guo,Wenyu Tian,Ying Yang,Yue Yin,Yaruo Qiu,Weixuan Wang,Yang Li,Guangze Zhang,Xuyang Zhao,Guangxi Wang,Zhiqiang Lin,Meng Yang,Wei Zhao,Dan Lu

DOI: https://doi.org/10.1158/2326-6066.27601852

2024-01-01

Abstract:Supplementary Table S2 Clinicopathological characteristics of patients for scRNA-seq data.
Supplementary Table 1 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Jianzhong Cao,Yongmei Song,Nan Bi,Jie Shen,Wenyang Liu,Jing Fan,Guogui Sun,Tong Tong,Jie He,Yuankai Shi,Xun Zhang,Ning Lu,Yinghua He,Hongyu Zhang,Kelong Ma,Xiaoying Luo,Lei Lv,Hui Deng,Jing Cheng,Jingde Zhu,Luhua Wang,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22397204

2023-01-01

Abstract:PDF file - 53K, The sequences for the four plasmids.
Supplementary Table S9 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434114

2024-01-01

Abstract:Sequence information of primers, siRNAs, shRNAs and sgRNAs.
Supplementary Table S1 from the Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma

Dan Lu,Dong,Yu Zhou,Min Lu,Xue-Wen Pang,Yan Li,Xiao-Jun Tian,Yu Zhang,Jun Zhang

DOI: https://doi.org/10.1158/1078-0432.22450682.v1

2023-01-01

Abstract:Supplementary Table S1 - PDF file 84K, Supplementary Table S1. Primers and oligonucleotides used in this study

Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Supplementary Table 4 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Distinct regulation of ASCL1 by the cell cycle and chemotherapy in small cell lung cancer

Table S1 from Spi-B–Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors

Supplementary Tables from A Novel Micropeptide Encoded by Y-Linked LINC00278 Links Cigarette Smoking and AR Signaling in Male Esophageal Squamous Cell Carcinoma

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Supplementary Table 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

Supplementary Table 1 from Hypoxic Glioma Stem Cell–Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis

Supplemental Table 1 from Genetic Variation in an Mirna-1827 Binding Site in MYCL1 Alters Susceptibility to Small-Cell Lung Cancer

Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities

Supplementary Tables 1-4 from Targeting FBW7 As a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Supplementary Tables from The Open Chromatin Landscape of Non–Small Cell Lung Carcinoma

Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Supplementary Table S6 from YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer

Supplementary Table S2 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence

Supplementary Table 1 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Table S9 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Supplementary Table S1 from the Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma